PL404315A1 - Lek i kompozycja farmaceutyczna zawierajaca 5-hydroksy-7-chloro-1[2-metylo-4(2-metylobenzoiloamino)benzoilo]-2,3,4,5-tetrahydro-1H-benzoazepine do leczenia ciezkiej niewydolnosci serca oraz zastosowanie tego zwiazku do wytwarzania leku - Google Patents
Lek i kompozycja farmaceutyczna zawierajaca 5-hydroksy-7-chloro-1[2-metylo-4(2-metylobenzoiloamino)benzoilo]-2,3,4,5-tetrahydro-1H-benzoazepine do leczenia ciezkiej niewydolnosci serca oraz zastosowanie tego zwiazku do wytwarzania lekuInfo
- Publication number
- PL404315A1 PL404315A1 PL404315A PL40431504A PL404315A1 PL 404315 A1 PL404315 A1 PL 404315A1 PL 404315 A PL404315 A PL 404315A PL 40431504 A PL40431504 A PL 40431504A PL 404315 A1 PL404315 A1 PL 404315A1
- Authority
- PL
- Poland
- Prior art keywords
- drug
- heart failure
- methylbenzoylamino
- tetrahydro
- benzoyl
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 5
- 206010019280 Heart failures Diseases 0.000 title abstract 4
- 229940079593 drug Drugs 0.000 title abstract 4
- GYHCTFXIZSNGJT-UHFFFAOYSA-N tolvaptan Chemical compound CC1=CC=CC=C1C(=O)NC(C=C1C)=CC=C1C(=O)N1C2=CC=C(Cl)C=C2C(O)CCC1 GYHCTFXIZSNGJT-UHFFFAOYSA-N 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title 1
- 150000003839 salts Chemical class 0.000 abstract 2
- 206010002383 Angina Pectoris Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000037081 physical activity Effects 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US44887803P | 2003-02-24 | 2003-02-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL404315A1 true PL404315A1 (pl) | 2013-08-05 |
Family
ID=32908667
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL404315A PL404315A1 (pl) | 2003-02-24 | 2004-02-23 | Lek i kompozycja farmaceutyczna zawierajaca 5-hydroksy-7-chloro-1[2-metylo-4(2-metylobenzoiloamino)benzoilo]-2,3,4,5-tetrahydro-1H-benzoazepine do leczenia ciezkiej niewydolnosci serca oraz zastosowanie tego zwiazku do wytwarzania leku |
| PL373432A PL218069B1 (pl) | 2003-02-24 | 2004-02-23 | Lek i kompozycja farmaceutyczna do zastosowania w leczeniu ciężkiej niewydolności serca oraz zastosowanie 5-hydroksy-7-chloro-1-[ 2-metylo-4-( 2-metylobenzoiloamino) benzoilo]-2,3,4,5-tetrahydro-1H-benzoazepiny do wytwarzania leku do leczenia ciężkiej niewydolności serca |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL373432A PL218069B1 (pl) | 2003-02-24 | 2004-02-23 | Lek i kompozycja farmaceutyczna do zastosowania w leczeniu ciężkiej niewydolności serca oraz zastosowanie 5-hydroksy-7-chloro-1-[ 2-metylo-4-( 2-metylobenzoiloamino) benzoilo]-2,3,4,5-tetrahydro-1H-benzoazepiny do wytwarzania leku do leczenia ciężkiej niewydolności serca |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US7423032B2 (https=) |
| EP (2) | EP2000142A1 (https=) |
| JP (2) | JP4771937B2 (https=) |
| KR (1) | KR100706727B1 (https=) |
| CN (1) | CN100577171C (https=) |
| AR (1) | AR043259A1 (https=) |
| AT (1) | ATE411803T1 (https=) |
| AU (2) | AU2004212842B9 (https=) |
| BR (1) | BRPI0405657A (https=) |
| CA (1) | CA2493475A1 (https=) |
| CY (1) | CY1108583T1 (https=) |
| DE (1) | DE602004017283D1 (https=) |
| DK (1) | DK1596868T3 (https=) |
| ES (1) | ES2315640T3 (https=) |
| MX (1) | MXPA05001623A (https=) |
| MY (1) | MY143740A (https=) |
| NO (1) | NO335369B1 (https=) |
| PL (2) | PL404315A1 (https=) |
| PT (1) | PT1596868E (https=) |
| RU (2) | RU2346689C2 (https=) |
| SI (1) | SI1596868T1 (https=) |
| TW (1) | TWI322689B (https=) |
| WO (1) | WO2004073716A1 (https=) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7468390B2 (en) * | 2002-01-17 | 2008-12-23 | Novartis Ag | Methods of treatment and pharmaceutical composition |
| TWI322689B (en) * | 2003-02-24 | 2010-04-01 | Otsuka Pharma Co Ltd | Method for treating severe heart failure and medicament therefor |
| DE102005003632A1 (de) | 2005-01-20 | 2006-08-17 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Katheter für die transvaskuläre Implantation von Herzklappenprothesen |
| US20070213813A1 (en) | 2005-12-22 | 2007-09-13 | Symetis Sa | Stent-valves for valve replacement and associated methods and systems for surgery |
| DK1968990T3 (da) | 2005-12-27 | 2015-04-27 | Otsuka Pharma Co Ltd | Vandopløselig benzoazepinforbindelse og farmaceutisk sammensætning deraf |
| JP5076327B2 (ja) * | 2006-02-01 | 2012-11-21 | 味の素株式会社 | 分岐鎖アミノ酸の心不全適応 |
| US7896915B2 (en) | 2007-04-13 | 2011-03-01 | Jenavalve Technology, Inc. | Medical device for treating a heart valve insufficiency |
| PT2146721E (pt) * | 2007-05-15 | 2013-07-18 | Otsuka Pharma Co Ltd | Métodos de utilização de antagonistas da vasopressina com agentes quimioterapeuticos de antraciclina para reduzir a cardiotoxicidade e/ou melhorar a sobrevivência |
| TWI405574B (zh) * | 2007-06-21 | 2013-08-21 | Otsuka Pharma Co Ltd | 藥學固體製劑及其製造方法 |
| US9044318B2 (en) | 2008-02-26 | 2015-06-02 | Jenavalve Technology Gmbh | Stent for the positioning and anchoring of a valvular prosthesis |
| WO2011104269A1 (en) | 2008-02-26 | 2011-09-01 | Jenavalve Technology Inc. | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
| US10856978B2 (en) | 2010-05-20 | 2020-12-08 | Jenavalve Technology, Inc. | Catheter system |
| CN103002833B (zh) | 2010-05-25 | 2016-05-11 | 耶拿阀门科技公司 | 人工心脏瓣及包括人工心脏瓣和支架的经导管输送的内假体 |
| JP5477413B2 (ja) * | 2012-04-24 | 2014-04-23 | 味の素株式会社 | 分岐鎖アミノ酸の心不全適応 |
| WO2015028209A1 (en) | 2013-08-30 | 2015-03-05 | Jenavalve Technology Gmbh | Radially collapsible frame for a prosthetic valve and method for manufacturing such a frame |
| WO2016150806A1 (en) | 2015-03-20 | 2016-09-29 | Jenavalve Technology, Inc. | Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath |
| CN107530168B (zh) | 2015-05-01 | 2020-06-09 | 耶拿阀门科技股份有限公司 | 在心脏瓣膜替换中具有降低的起搏器比例的装置和方法 |
| CN109475419B (zh) | 2016-05-13 | 2021-11-09 | 耶拿阀门科技股份有限公司 | 用于通过引导鞘和装载系统来递送心脏瓣膜假体的心脏瓣膜假体递送系统和方法 |
| CN110392557A (zh) | 2017-01-27 | 2019-10-29 | 耶拿阀门科技股份有限公司 | 心脏瓣膜模拟 |
| CN110174474B (zh) * | 2019-05-24 | 2022-02-18 | 石家庄四药有限公司 | 复方电解质注射液(ⅱ)中l-苹果酸异构体的检测方法 |
| CN112121051B (zh) * | 2020-09-30 | 2021-06-18 | 郑州大学 | 莫扎伐坦在制备抗消化道肿瘤药物中的应用 |
| CN120152682A (zh) | 2022-11-09 | 2025-06-13 | 耶拿阀门科技公司 | 用于顺序地部署可扩张植入物的导管系统 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH01102124A (ja) | 1987-10-14 | 1989-04-19 | Kubota Ltd | コンクリート構造体支持構造 |
| US5753677A (en) * | 1989-10-20 | 1998-05-19 | Otsuka Pharmaceutical Co., Ltd. | Benzoheterocyclic compounds |
| US5258510A (en) | 1989-10-20 | 1993-11-02 | Otsuka Pharma Co Ltd | Benzoheterocyclic compounds |
| DK0450097T3 (da) | 1989-10-20 | 1996-05-20 | Otsuka Pharma Co Ltd | Benzoheterocykliske forbindelser |
| AU657424B2 (en) | 1992-07-02 | 1995-03-09 | Otsuka Pharmaceutical Co., Ltd. | Oxytocin antagonist |
| JPH0680641A (ja) | 1992-09-01 | 1994-03-22 | Otsuka Pharmaceut Co Ltd | 光学活性な５−ヒドロキシベンゾアゼピン誘導体の製造法 |
| TW354762B (en) | 1993-02-23 | 1999-03-21 | Otsuka Pharma Co Ltd | Agent for prophylaxis or treatment of cataract |
| JP2694319B2 (ja) | 1993-12-24 | 1997-12-24 | 大塚製薬株式会社 | 抗潰瘍剤 |
| JP3002766B2 (ja) | 1994-12-09 | 2000-01-24 | 大塚製薬株式会社 | 脳浮腫治療剤 |
| JPH10120592A (ja) | 1996-10-22 | 1998-05-12 | Otsuka Pharmaceut Co Ltd | メニエール病乃至メニエール症候群治療剤 |
| JP4210355B2 (ja) | 1997-07-03 | 2009-01-14 | 大塚製薬株式会社 | 固形製剤組成物 |
| EP1253945B1 (en) | 2000-01-26 | 2006-10-04 | Astellas Pharma Inc. | Ace inhibitor-vasopressin antagonist combinations |
| US20030103983A1 (en) * | 2002-05-09 | 2003-06-05 | Pressler Milton Lethan | Ace inhibitor-vasopressin antagonist combinations |
| US20030008860A1 (en) | 2002-05-09 | 2003-01-09 | Bakker-Arkema Rebecca Guggemos | Treatment of congestive heart failure |
| ES2288899T3 (es) * | 2000-10-04 | 2008-02-01 | Astellas Pharma Inc. | Uso de un antagonista de vasopresina tal como conivaptan en la fabricacion de un medicamento para el tratamiento de la hipertension pulmonar. |
| TWI322689B (en) * | 2003-02-24 | 2010-04-01 | Otsuka Pharma Co Ltd | Method for treating severe heart failure and medicament therefor |
-
2004
- 2004-02-05 TW TW093102582A patent/TWI322689B/zh not_active IP Right Cessation
- 2004-02-17 MY MYPI20040510A patent/MY143740A/en unknown
- 2004-02-23 PT PT04713672T patent/PT1596868E/pt unknown
- 2004-02-23 AR ARP040100557A patent/AR043259A1/es unknown
- 2004-02-23 PL PL404315A patent/PL404315A1/pl unknown
- 2004-02-23 DK DK04713672T patent/DK1596868T3/da active
- 2004-02-23 JP JP2006502681A patent/JP4771937B2/ja not_active Expired - Lifetime
- 2004-02-23 ES ES04713672T patent/ES2315640T3/es not_active Expired - Lifetime
- 2004-02-23 AT AT04713672T patent/ATE411803T1/de active
- 2004-02-23 CN CN200480000735A patent/CN100577171C/zh not_active Expired - Lifetime
- 2004-02-23 US US10/523,020 patent/US7423032B2/en not_active Expired - Lifetime
- 2004-02-23 DE DE602004017283T patent/DE602004017283D1/de not_active Expired - Lifetime
- 2004-02-23 SI SI200430894T patent/SI1596868T1/sl unknown
- 2004-02-23 EP EP08162362A patent/EP2000142A1/en not_active Withdrawn
- 2004-02-23 BR BR0405657-4A patent/BRPI0405657A/pt not_active Application Discontinuation
- 2004-02-23 CA CA002493475A patent/CA2493475A1/en not_active Abandoned
- 2004-02-23 EP EP04713672A patent/EP1596868B1/en not_active Expired - Lifetime
- 2004-02-23 PL PL373432A patent/PL218069B1/pl unknown
- 2004-02-23 AU AU2004212842A patent/AU2004212842B9/en not_active Expired
- 2004-02-23 RU RU2005102110/14A patent/RU2346689C2/ru active
- 2004-02-23 KR KR1020057002579A patent/KR100706727B1/ko not_active Expired - Lifetime
- 2004-02-23 WO PCT/JP2004/002085 patent/WO2004073716A1/en not_active Ceased
- 2004-02-23 MX MXPA05001623A patent/MXPA05001623A/es active IP Right Grant
-
2005
- 2005-02-02 NO NO20050569A patent/NO335369B1/no unknown
-
2008
- 2008-05-05 US US12/149,578 patent/US7749993B2/en not_active Expired - Lifetime
- 2008-08-15 RU RU2008133654/14A patent/RU2008133654A/ru not_active Application Discontinuation
- 2008-11-20 CY CY20081101341T patent/CY1108583T1/el unknown
-
2009
- 2009-03-19 AU AU2009201109A patent/AU2009201109A1/en not_active Abandoned
-
2011
- 2011-03-07 JP JP2011049403A patent/JP2011148806A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL404315A1 (pl) | Lek i kompozycja farmaceutyczna zawierajaca 5-hydroksy-7-chloro-1[2-metylo-4(2-metylobenzoiloamino)benzoilo]-2,3,4,5-tetrahydro-1H-benzoazepine do leczenia ciezkiej niewydolnosci serca oraz zastosowanie tego zwiazku do wytwarzania leku | |
| Madhusoodanan et al. | Clinical experience with quetiapine in elderly patients with psychotic disorders | |
| WO2005065069A3 (en) | Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease | |
| KR20200016889A (ko) | 과다 졸림증을 치료하기 위한 방법 및 조성물 | |
| EA200800056A1 (ru) | Каннабиноидный активный фармацевтический ингредиент для лекарственных форм | |
| ATE493981T1 (de) | Einmal tägliche dosierformen von trospium | |
| WO2002088100A3 (de) | Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel | |
| BR9915610A (pt) | Preparações farmacêuticas combinadas | |
| CA2474430A1 (en) | A combination of a thrombolytic agent and levosimendan for the treatment of acute myocardial infarction | |
| MXPA02006511A (es) | Complejo que comprende factor inhibidor de osteoclastogenesis y polisacarido. | |
| CA2450915A1 (en) | Use of levosimendan and beta-adrenergic receptor antagonist for the treatment of heart failure | |
| JP2002535367A5 (https=) | ||
| CA2501772A1 (en) | Use of dihydroimidazolones for the treatment of epilepsy in dogs | |
| RU2008110933A (ru) | Применение амброксола для лечения риновирусных инфекций | |
| HUP0301408A2 (hu) | Szulodexid alkalmazása diabetikus vesebetegség kezelésére szolgáló orális gyógyszerkészítmény előállítására | |
| AR030551A1 (es) | Uso de nefiracetam para la fabricacion de un medicamento para eltratamiento de la neurodegeneracion y composicion farmaceutica resultante | |
| AU2012276476B2 (en) | Pharmaceutical composition for treating premature ejaculation and method for treating premature ejaculation | |
| MA28036A1 (fr) | Utilisation d'oxcarbazepine dans le traitement de la douleur liee a la neuropathie diabetique et dans l'amelioration du sommeil | |
| CA2469702A1 (en) | Darifenacin for use in the treatment of urgency induced by overactive bladder | |
| Jašović-Gašić et al. | P. 6.024 Antidepressants versus clozapine in the treatment of depressive syndrome in schizophrenia | |
| Iván et al. | COMPARATIVE STUDY ON TOBANUM/GYKI-41099/AND PINDOLOL ON PATIENTS SUFFERING FROM MODERATE OR SEVERE HYPERTENSION | |
| PT1490049E (pt) | Citalopram para o tratamento da pre3ssao sanguinia elevada. | |
| TW200515912A (en) | Use of oxcarbazepine for the treatment of diabetic neuropathic pain and the improvement of sleep | |
| HUP0401587A2 (hu) | Új elnyújtott kibocsátású orális adagolási forma | |
| Hemmeter et al. | P. 6.023 Effect of zopiclone on cognition and sleep-EEG in healthy elderly volunteers |